Avantor, Inc. (NYSE:AVTR) Shares Acquired by Teachers Retirement System of The State of Kentucky

Teachers Retirement System of The State of Kentucky lifted its holdings in Avantor, Inc. (NYSE:AVTR - Free Report) by 45.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 723,178 shares of the company's stock after acquiring an additional 227,200 shares during the quarter. Teachers Retirement System of The State of Kentucky owned 0.11% of Avantor worth $18,708,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Cetera Advisors LLC purchased a new position in Avantor during the first quarter valued at approximately $249,000. SG Americas Securities LLC increased its holdings in shares of Avantor by 222.0% during the 2nd quarter. SG Americas Securities LLC now owns 19,996 shares of the company's stock valued at $424,000 after purchasing an additional 13,786 shares in the last quarter. Wealth Enhancement Advisory Services LLC lifted its stake in shares of Avantor by 2.8% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 26,921 shares of the company's stock valued at $571,000 after purchasing an additional 733 shares during the period. ORG Partners LLC boosted its holdings in Avantor by 5,773.0% during the second quarter. ORG Partners LLC now owns 5,873 shares of the company's stock worth $122,000 after buying an additional 5,773 shares in the last quarter. Finally, PGGM Investments purchased a new stake in Avantor during the second quarter worth $238,000. Institutional investors and hedge funds own 95.08% of the company's stock.

Avantor Trading Down 0.6 %

Avantor stock traded down $0.13 during midday trading on Thursday, hitting $22.53. 4,309,220 shares of the stock were exchanged, compared to its average volume of 6,484,671. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84. The stock has a market capitalization of $15.33 billion, a price-to-earnings ratio of 48.98, a PEG ratio of 2.59 and a beta of 1.29. The stock's 50-day simple moving average is $22.59 and its 200 day simple moving average is $23.55. Avantor, Inc. has a fifty-two week low of $19.59 and a fifty-two week high of $28.00.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Royal Bank of Canada reissued an "outperform" rating and set a $34.00 target price on shares of Avantor in a research note on Thursday, September 26th. Robert W. Baird lowered their price target on Avantor from $27.00 to $26.00 and set an "outperform" rating on the stock in a research report on Monday, October 28th. Barclays cut their price objective on Avantor from $28.00 to $25.00 and set an "overweight" rating for the company in a research report on Friday, October 25th. Wells Fargo & Company decreased their target price on Avantor from $30.00 to $28.00 and set an "overweight" rating on the stock in a research report on Monday, October 28th. Finally, UBS Group dropped their price target on shares of Avantor from $30.00 to $29.00 and set a "buy" rating on the stock in a research note on Tuesday, October 8th. Three research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $27.69.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.